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b Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, United StatesZika virus (ZIKV), the mosquito-borne ﬂavivirus responsible for the from French Polynesia (PF-13, 2013) and one African (AF ZIKV) from
current outbreak in Latin America,wasﬁrst isolated in 1947. Nevertheless,
the link between ZIKV and the neurological complications observed in
humans, like Guillain-Barré syndrome (GBS) and microcephaly, was
not formally established until April 2016 by the Centers for Disease
Control and Prevention (CDC). Although retrospective studies have also
conﬁrmed the link in a previous outbreak in French Polynesia (2013),
how these clinical signs could have gone unnoticed for almost 70 years
while the virus had been circulating in Africa and Asia is surprising. The
existing isolates of ZIKV have been classiﬁed in two main lineages,
African and Asian, although a recent report has identiﬁed a third one,
where the original African lineage was renamed to African-I, and a
previously neglected lineage circulating in Senegal and Cote d'Ivoire
has been named African-II (Gong et al., 2016). The Asian lineage was
the one that spread to Oceania's islands and the Americas, and two
main hypotheses have been proposed for the unexpected clinical
outcome of ZIKV in the last outbreaks. On one hand, clinical signs could
have been overlooked due to poor surveillance in low-income territories.
The other possibility would be that the new derived strains would have
genetically changed enough to differ in their pathogenesis (Panchaud
et al., 2016).
Reports on ZIKV have been scarce for many years, until a Public
Health Emergency of International Concern (PHEIC) was issued by the
World Health organization (WHO) in February 2016, engaging the sci-
entiﬁc community in an unprecedented effort to develop a coordinated
global response. Although both Asian and African ZIKV strains have
been shown to be neurovirulent (Barzon et al., 2016), the only African
strain used for those studies (MR-766, 1947) has been extensively
passaged in suckling mice brains (Haddow et al., 2012). This may have
added multiple mutations that could affect the observed results,
especially considering ZIKV is an RNA virus. Hence, there is still a need
to clarify if the newly-found clinical manifestations are speciﬁc for the
Asian lineage, or could have also been induced by the African ZIKV.
In this issue of EBioMedicine, Simonin et al. (2016) compare the
infectivity of two low-passage isolates of ZIKV, one Asian (AS ZIKV)DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.09.020.
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strains from the African lineage-I. They observe that the AF ZIKV strain
presents higher levels of infectivity and virus production than the AS
ZIKV strain in human pluripotent stem cell-derived neural stem cells
(iPS-derivedNSCs) and in astrocytes. These results contradict a previous
report on human neuro-precursor cells (NPCs), where lower replication
was observed for the AF ZIKV strain compared to an AS ZIKV one;
nevertheless, the African strain MR-766 was used for the infections in
that study (Cugola et al., 2016). Additionally, Simonin et al. found a
stronger halt in cell division, together with higher levels of induction
of apoptosis when the NSCs were infected with the AF ZIKV strain
compared to the AS ZIKV strain. High levels of cell death were reported
before in NPCs and brain organoids infected with the MR-766 strain
(Qian et al., 2016; Tang et al., 2016), but it is still unclear how this strain
compares to the AS andAF ones. Simonin et al. also observed an increase
in the expression of several antiviral genes upon infection of AF ZIKV
(RIG-I, MDA5, TLR3 and IFN-β) that was not induced by the AS ZIKV
strain. This lack of antiviral gene-modulation by the AS ZIKV strain
agrees with what has been previously observed in NPCs (Hanners
et al., 2016). Together, these results could point to viral persistence of
AS ZIKV in the infected neural tissues by establishing a reservoir due
to a lack of strong immune response in that tissue, which could explain
the detection of ZIKV in neonates that were more likely infected early
during pregnancy (de Araujo et al., 2016).
These interesting data would support the hypothesis of the change
in phenotype from the African to the Asian lineage, provided that this
study is further conﬁrmed using additional primary isolates for a
whole comparison. An effort in obtaining all the complete sequences
of the isolated strains will be essential to determine the differences
between ZIKV strains that could lead to a change in virulence, which
could be tested by the use of reverse genetics. Additionally, differences
in survival and vertical transmission rates could be analyzed using the
available mouse models. Lastly, it would be important to increase the
surveillance and traceability efforts of infectious cases, as the possibility
exists that more ZIKV outbreaks could remain undiscovered in Africa.
In sum, Simonin et al. have contributed with this work to the
research on the newly-found clinical manifestations in Asia and America
showing how two strains can have different phenotypes when infecting
neural cells. The conﬁrmation that these phenotypes are respectivelythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
36 A.M. Maestre, A. Fernandez-Sesma / EBioMedicine 13 (2016) 35–36maintained both in the African and Asian ZIKV lineages will be essential
to decipher the determinant factors responsible for the current ZIKV's
pathology. Ultimately, understanding themechanistic pathways underly-
ing the respective clinical outcomes will help to effectively control the
current outbreak.
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